Press-release for stocks for NVS

symbols : NVS crawled time : 01:00

save search

Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| -4.76% | O: -0.23% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -6.71% | O: -0.07% H: 0.09% C: -0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -10.2% | O: 0.66% H: 0.0% C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABBV | News | $166.41 1.06% 0.0% 5.5M

Health Technology

| -8.97% | O: 0.59% H: 0.01% C: -1.45%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.85% | O: -0.04% H: 0.0% C: 0.0%
report research global

Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published: 2024-03-05 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -8.72% | O: 0.32% H: 0.22% C: -0.2%
ABBV | News | $166.41 1.06% 0.0% 5.5M

Health Technology

| -7.56% | O: -0.24% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.17% | O: 1.17% H: 0.0% C: 0.0%
report sciences global key market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $138.24 -4.19% 800

Health Technology

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K

Manufacturing

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 -1.11% 520K

Manufacturing

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -5.13% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $166.41 1.06% 0.0% 5.5M

Health Technology

| -6.33% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.44% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

Health Technology

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| -6.54% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -6.65% | O: -1.67% H: 1.17% C: 0.85%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -5.72% | O: 1.81% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -6.86% | O: 1.16% H: 0.14% C: -1.89%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| -5.92% | O: -0.11% H: 0.5% C: -1.78%
cancer global immunotherapy market

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| -2.46% | O: 1.56% H: 0.51% C: 0.51%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -4.32% | O: 0.45% H: 0.75% C: 0.46%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| -2.65% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -3.34% | O: 0.75% H: 0.55% C: 0.27%
fabhalta novartis trial results

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 12.22% | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 3.73% | O: 0.94% H: 2.55% C: 2.55%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 2.99% | O: 2.52% H: 0.04% C: 0.04%
NVO | $122.71 -0.03% 0.17% 5M

Health Technology

| 28.95% | O: 0.87% H: 0.73% C: 0.28%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -0.53% | O: 0.16% H: 0.7% C: 0.57%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 10.92% | O: -4.06% H: 1.9% C: 0.96%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 32.11% | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -0.11% | O: 0.18% H: 0.0% C: 0.0%
expected reach global dna medical technology market

Key Players in Motion Sickness Drugs Market Include GlaxoSmithKline, Novartis, and Teva Pharmaceuticals
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| -1.63% | O: -3.68% H: 0.0% C: 0.0%
VTRS | $11.25 1.17% 1.16% 4.7M

Health Technology

| 23.69% | O: 0.0% H: 0.17% C: -2.45%
PBH | $69.67 1.93% 0.0% 450K

Health Technology

| 14.03% | O: -0.28% H: 0.57% C: -1.08%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -1.29% | O: -0.23% H: 0.08% C: -1.92%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 10.99% | O: -0.7% H: 0.0% C: -2.46%
BAX | $39.47 -0.45% 0.0% 2.8M

Health Technology

| 22.34% | O: 0.71% H: 0.26% C: -1.59%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 14.05% | O: 1.57% H: 0.6% C: -2.01%
pharmaceuticals teva market

Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -1.63% | O: -3.68% H: 0.0% C: 0.0%
VTRS | $11.25 1.17% 1.16% 4.7M

Health Technology

| 23.69% | O: 0.0% H: 0.17% C: -2.45%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -1.29% | O: -0.23% H: 0.08% C: -1.92%
BHC | $8.69 1.05% 0.0% 2.9M

Health Technology

| 29.87% | O: -0.59% H: 0.15% C: -1.79%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -14.36% | O: -15.73% H: 0.0% C: 0.0%
BCLI | $0.5384 4.69% 4.48% 1M

Health Technology

| 216.77% | O: 3.73% H: 1.8% C: -4.19%
BIIB | $194.39 2.03% 1.99% 1.6M

Health Technology

| -19.05% | O: -0.45% H: 0.12% C: -2.28%
propel disease research therapeutics growth market

Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M

Health Technology

| 24.66% | O: 0.45% H: 2.46% C: 1.67%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -1.7% | O: -0.17% H: 1.02% C: 0.4%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -12.46% | O: 0.77% H: 0.0% C: 0.0%
reach research market

North America Leads the Global Peptide Drug Conjugates Market Due to Increased Cancer Incidence
Published: 2023-10-20 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -1.65% | O: 0.6% H: 0.61% C: -0.56%
america drug cancer global market

Wegener's Granulomatosis Treatment Market on the Rise: Increased Awareness and Advancements Drive Projected 5.9% CAGR Growth by 2031
Published: 2023-09-19 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| 11.14% | O: -1.83% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -8.81% | O: 0.41% H: 0.47% C: 0.41%
SNOA | $0.1539 -1.72% -1.75% 170K

Health Technology

| -82.42% | O: 0.0% H: 0.0% C: -3.29%
HALO M | $38.64 2.2% 2.15% 1.3M

Health Technology

| -3.32% | O: 0.18% H: 1.89% C: 1.51%
treatment growth market

Empowering Healthcare: Global Vaccine Management System Market to Reach $441.17 million by 2028
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 11.79% | O: -1.57% H: 0.0% C: 0.0%
AZNCF | $138.24 -4.19% 800

Health Technology

| -2.73% | O: 0.56% H: 0.0% C: -2.26%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -9.88% | O: -0.25% H: 0.47% C: -1.08%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -11.98% | O: 0.56% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 11.52% | O: 0.54% H: 0.27% C: -0.59%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -15.71% | O: 0.66% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

Health Technology

| -1.27% | O: 0.46% H: 0.17% C: -0.86%
management vaccine reach global system market

Autism Spectrum Disorder Therapeutics Market to Grow by USD 772.65 million from 2022 to 2027 | Increasing prevalence of ASD boosts the market growth - Technavio
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
QBIO | $0.0002 100.0% 1.1K

Professional, Scientific, and T...

| -99.97% | O: -27.59% H: 0.0% C: 0.0%
TVTX | $5.73 -1.21% -1.22% 950K

Health Technology

| -54.34% | O: 0.69% H: 0.98% C: -0.15%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -9.88% | O: -0.25% H: 0.47% C: -1.08%
JAZZ | $109.96 0.63% 0.63% 760K

Health Technology

| -24.82% | O: 1.08% H: 1.22% C: 0.92%
therapeutics growth market

Germany Pharmaceuticals Market size to grow by USD 21.44 billion from 2022 to 2027|The high investment in the pharmaceutical industry boosts market growth - Technavio
Published: 2023-07-26 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 14.45% | O: 1.5% H: 0.64% C: 0.64%
BABAF | News | $8.76 2.05% 6.5K

Retail Trade

| -27.67% | O: 2.54% H: 0.65% C: 0.65%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -11.2% | O: -0.89% H: 0.27% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 10.92% | O: 0.14% H: 0.64% C: 0.34%
ABBV | News | $166.41 1.06% 0.0% 5.5M

Health Technology

| 15.97% | O: -0.67% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -5.82% | O: -0.49% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -15.57% | O: -1.57% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| 12.59% | O: -0.58% H: 0.77% C: 0.54%
germany pharmaceuticals growth market

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 11.2% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -16.61% | O: -0.95% H: 0.19% C: -0.32%
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -31.09% | O: 0.19% H: 0.11% C: -1.46%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -6.46% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -11.42% | O: 0.03% H: 0.12% C: -0.24%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 9.18% | O: -0.91% H: 0.56% C: -0.5%
LLY | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 65.82% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -25.45% | O: -0.06% H: 0.46% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

Health Technology

| -4.83% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

Global Hearing Loss Disease Treatment Market Report 2023: Rising Prevalence of Hearing Loss Drives Growth
Published: 2023-06-15 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -6.62% | O: 1.04% H: 0.78% C: 0.67%
disease report treatment global growth market

Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published: 2023-05-17 (Crawled : 01:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800

Health Technology

| -10.51% | O: -1.32% H: 0.92% C: -1.34%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -9.46% | O: -0.51% H: 0.0% C: -1.05%
FUSN | $21.26 0.05% 0.05% 440K

Health Technology

| 365.79% | O: -1.54% H: 1.34% C: -2.67%
DFFN 4 | $6.6 11.68% -34.32% 350K

Health Technology

| 14.59% | O: -0.25% H: 0.0% C: -0.78%
AZN | $68.56 0.29% 0.29% 4.7M

Health Technology

| -9.32% | O: 0.07% H: 0.03% C: -0.84%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| 16.26% | O: -0.82% H: 0.03% C: -0.44%
propel report expected treatment global growth glioblastoma market

Doxorubicin market size to grow by USD 469.97 million from 2022 to 2027; Growth driven by increasing prevalence of cancer cases - Technavio
Published: 2023-05-05 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -11.03% | O: -0.77% H: 1.03% C: 0.88%
BAX | $39.47 -0.45% 0.0% 2.8M

Health Technology

| -12.34% | O: 0.55% H: 1.38% C: 1.12%
cancer doxorubicin growth market

Orphan drugs market to grow by USD 170.8 billion between 2022 and 2027; Growth driven by rising incidence of rare diseases - Technavio
Published: 2023-05-03 (Crawled : 01:00) - prnewswire.com
CSLLY | $86.918 3.3% 60K

n/a

| -12.47% | O: -0.56% H: 0.36% C: -0.28%
AZNCF | $138.24 -4.19% 800

Health Technology

| -7.42% | O: 3.52% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 10.16% | O: -1.96% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K

Manufacturing

| -38.02% | O: 1.86% H: 0.0% C: -0.65%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -10.1% | O: 0.55% H: 0.68% C: 0.33%
GSK | $39.75 1.22% 0.0% 1.6M

Health Technology

| 8.94% | O: 1.24% H: 1.14% C: 0.11%
ABBV | News | $166.41 1.06% 0.0% 5.5M

Health Technology

| 8.93% | O: -0.36% H: 0.29% C: -1.2%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -14.78% | O: 0.71% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M

Health Technology

| -7.37% | O: 0.75% H: 0.98% C: 0.46%
rare growth market

← Previous
1
2
3
Next →

symbols : NVS crawled time : 01:00

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

symbols : NVS crawled time : 01:00 save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

symbols : NVS crawled time : 01:00

save search